Aspira Women's Health Inc. Watch

from 8-K 44 pages At the Market Offering Agreement

from 8-K/A 9 pages Placement Agency Agreement

from 8-K 9 pages Placement Agency Agreement

from 8-K 39 pages Aspira Women’s Health Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement

from 8-K 56 pages Aspira Women’s Health Inc. Common Stock, Par Value $0.001 Per Share, and Warrants to Purchase Common Stock Underwriting Agreement

from 8-K 33 pages Aspira Women’s Health Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement

from 8-K 32 pages Vermillion, Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement

from 8-K 33 pages 50,000shares Vermillion, Inc. Series B Convertible Preferred Stock Underwriting Agreement

from 8-K 34 pages 10,000,000 Shares Vermillion, Inc. Common Stock Underwriting Agreement

from 8-K 32 pages Vermillion, Inc. 8,350,000 Shares Common Stock ($0.001 Par Value) Underwriting Agreement Underwriting Agreement

from S-3 34 pages Vermillion, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement

from S-1/A 31 pages — Shares Vermillion, Inc. Common Stock Underwriting Agreement

from SC 13G/A 1 page Ex-1.1 Otherdoc 2 0002.txt Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on Schedule 13g/A, Dated November 21, 2002, (The "Schedule 13g/A"), With Respect to the Common Stock, $.001 Par Value, of Ciphergen Biosystems Inc. Is, and Any Amendments Thereto Executed by Each of US Shall Be, Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to the Schedule 13g/a and Each Such Amendment. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g/a and Any Amendments Thereto, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 21st Day of November, 2002. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member Samuel D. Isaly By: /S/ Samuel D. Isaly Samuel D. Isaly

from SC 13G/A 1 page Ex-1.1 Otherdoc 2 0002.txt Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on Schedule 13g/A, Dated November 21, 2002, (The "Schedule 13g/A"), With Respect to the Common Stock, $.001 Par Value, of Ciphergen Biosystems Inc. Is, and Any Amendments Thereto Executed by Each of US Shall Be, Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to the Schedule 13g/a and Each Such Amendment. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g/a and Any Amendments Thereto, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 21st Day of November, 2002. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member Samuel D. Isaly By: /S/ Samuel D. Isaly Samuel D. Isaly

from SC 13G/A 1 page Ex-1.1 Otherdoc 2 0002.txt Joint Filing Agreement Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on Schedule 13g/A, Dated November 21, 2002, (The "Schedule 13g/A"), With Respect to the Common Stock, $.001 Par Value, of Ciphergen Biosystems Inc. Is, and Any Amendments Thereto Executed by Each of US Shall Be, Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to the Schedule 13g/a and Each Such Amendment. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g/a and Any Amendments Thereto, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 21st Day of November, 2002. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member Samuel D. Isaly By: /S/ Samuel D. Isaly Samuel D. Isaly

from SC 13G 1 page <page> Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on Schedule 13g, Dated May 24, 2001, (The "Schedule 13g"), With Respect to the Common Stock, $.001 Par Value, of Ciphergen Biosystems Inc. Is, and Any Amendments Thereto Executed by Each of US Shall Be, Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to the Schedule 13g and Each Such Amendment. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g and Any Amendments Thereto, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 24th Day of May, 2001. Orbimed Advisers Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member

from S-1/A ~20 pages Underwriting agreement